THANK YOU FOR SUBSCRIBING
By Jill Hoffman, Director Of Global Quality And Food Safety, Mccormick & Co. Inc
By Andrew Norton, Director of Business Development, Liviri
By Celia Martin, Director Global Regulatory Affairs, Lallemand
By Monica Popescu, Coca-Cola HBC Business Systems Solutions - SC/Quality Solutions Manager, Coca-Cola HBC and Zoltan Syposs, Ph.D., Coca-Cola HBC QSE Director, Honorary Associate Professor University of Szent Istvan / Food Science Department Hungary
Food and Beverages | Monday, August 16, 2021
ZIPPZ announced the appointment of two well-known cannabis medical advisors to the brand, Dr. June Chin and Dr. Jessica Knox.
FREMONT, CA: ZIPPZ, the first personalized natural CBD wellness firm, has recently announced the appointment of two well-known cannabis medical advisors to the brand, Dr. June Chin and Dr. Jessica Knox, both cannabinoid and preventative medicine experts. By 2025, the legal cannabis industry in the United States is expected to reach $43 billion, with 22.2 million monthly consumers. Add in the fast-expanding market for cannabis-based products that require little or no physician participation, and companies have a nation of people looking for high-quality therapeutic treatments.
ZIPPZ is disrupting the sleep and stress market by offering unique CBD and plant-based products as an option to OTC and Rx medicines. Dr. Chin and Dr. Knox will use their natural pharmacology-based method from their clinics to help ZIPPZ promote cannabis as a holistic medical alternative.
"ZIPPZ understands that sleep disruption and increased levels of stress and anxiousness are driven by dramatically different things for different people," says ZIPPZ CEO Scott Eagle." The solution requires a unique and personalized product catered to each individual's health needs, not a generic one-size-fits-all approach. We are thrilled to welcome Dr. Chin and Dr. Knox to help guide our custom solutions and advance our mission as an integrative medical approach."
"As a chronic pain survivor, I have been an advocate for the application of medical cannabis throughout my career," stated Dr. Chin. "More integrative and holistic approaches to patient care is exactly what we need. I'm honored to work with the ZIPPZ team to advance this important vision while creating affordable and personalized CBD therapies for those who seek relief from stress and pain."
As part of ZIPPZ's one-of-a-kind strategy, the company uses each customer's comprehensive online exam to gain a comprehensive picture of their disease, severity, age, gender, and lifestyle. ZIPPZ then customizes formula recommendations for each user, including a "trial sampling" method that allows customers to find the appropriate ZIPPZ formula for their specific needs.
Dr. Knox stated, "I am particularly drawn to the ZIPPZ personalized consumer assessment, as health needs should be treated for individual requirements. ‹‹I look forward to applying my experience in refining the cannabinoid system and medical applications to advise ZIPPZ on their vision that each customer receives a unique remedy for their health and wellness needs."
ZIPPZ has optimized the effectiveness of 35 established botanicals, such as CBD, by incorporating network pharmacology concepts to design products that fit every consumer's specific requirement. ZIPPZ provides hundreds of possible formula combinations, paving the path for effective natural health treatments.
Read Also
ON THE DECK
Processing and Packaging 2023
Top Vendors
Cannabis Tech Europe 2022
Top Vendors